PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Institute of Clinical Microbiology and Hygiene, University Hospital Regensburg, Regensburg, Germany.\', \'Department for Infection Control and Infectious Diseases, University Hospital Regensburg, Regensburg, Germany.\', \'Kliniken Südostbayern, Traunstein, Germany.\', \'Institute for Medical Microbiology and Hygiene, University of Regensburg, Regensburg, Germany.\', \'Institute for Medical Microbiology and Hygiene, University of Regensburg, Regensburg, Germany. david.peterhoff@ur.de.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1007/s15010-021-01598-6
?:hasPublicationType
?:journal
  • Infection
is ?:pmid of
?:pmid
?:pmid
  • 33689159
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.171
?:rankingScore_hIndex
  • 64
?:title
  • SARS-CoV-2-directed antibodies persist for more than six months in a cohort with mild to moderate COVID-19.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all